-
Mashup Score: 1
Purpose In patients with type 2 diabetes mellitus (T2DM), both sodium-glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide receptor agonists (GLP-1 RAs) have demonstrated significant improvements in cardiovascular and kidney outcomes independent of their glycemic benefits. This paper will briefly compare the effect of SGLT2is and GLP-1 RAs to that of the SGLT1/2 inhibitor…
Source: Cardiovascular Drugs and TherapyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 19
The chronic coronary syndromes (CCS) include patients with a classic history of angina pectoris in the presence of either risk factors for or known atherosclerotic coronary artery disease. Randomized, controlled trials conducted in the optimal medical therapy (OMT) era have convincingly demonstrated that adherence to the outdated paradigm focused on treatment of obstructive coronary disease with…
Source: Cardiovascular Drugs and TherapyCategories: Cardiologists, Latest HeadlinesTweet-
RT @DavidLBrownMD: Latest paper about the rationale of OMT for therapy of chronic coronary syndromes. https://t.co/vvzxSDdmz2
-
-
Mashup Score: 40
The chronic coronary syndromes (CCS) include patients with a classic history of angina pectoris in the presence of either risk factors for or known atherosclerotic coronary artery disease. Randomized, controlled trials conducted in the optimal medical therapy (OMT) era have convincingly demonstrated that adherence to the outdated paradigm focused on treatment of obstructive coronary disease with…
Source: Cardiovascular Drugs and TherapyCategories: Cardiologists, Latest HeadlinesTweet-
Latest paper about the rationale of OMT for therapy of chronic coronary syndromes. https://t.co/vvzxSDdmz2
-
-
Mashup Score: 1Challenges in Optimizing Lipid Management in Women - Cardiovascular Drugs and Therapy - 3 year(s) ago
While there are physiologic differences in lipid metabolism in men and women, pharmacologic therapy is very effective in both with similar management strategies recommended in the current guidelines for the management of dyslipidemia. Despite similar guidelines for treatment, studies have shown that women have worse control of dyslipidemia than their male counterparts. This may stem from multiple…
Source: Cardiovascular Drugs and TherapyCategories: Cardiologists, Latest HeadlinesTweet-
Great collaboration with this 💪 @albanymedical team on lipid ⬇️ in 💃Resource for trial data & treatment. Dr. Radmilla Lyubarova Dr. Mandeep Sidhu Dr. Kim Poli Dr. Sulagna Mookherjee@Gurleen_Kaur96 @lenoxhill @northwell @NLAWIL #NYACCWIC https://t.co/FAR8wHtuqU https://t.co/ts1K8jB4xo
-
-
Mashup Score: 3Electrical Stimulation for Low-Energy Termination of Cardiac Arrhythmias: a Review - Cardiovascular Drugs and Therapy - 3 year(s) ago
Cardiac arrhythmias are a leading cause of morbidity and mortality in the developed world, estimated to be responsible for hundreds of thousands of deaths annually. Our understanding of the electrophysiological mechanisms of such arrhythmias has grown since they were formally characterized in the late nineteenth century, and this has led to the development of numerous devices and therapies that…
Source: Cardiovascular Drugs and TherapyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Electrical Stimulation for Low-Energy Termination of Cardiac Arrhythmias: A Review Learn more: https://t.co/PrDqmmCQ6i @MehdiRazavi13 #THI #THIresearch #defibrillation #AFib https://t.co/HHzP8Q9ewe
-
-
Mashup Score: 1Electrical Stimulation for Low-Energy Termination of Cardiac Arrhythmias: a Review - Cardiovascular Drugs and Therapy - 3 year(s) ago
Cardiac arrhythmias are a leading cause of morbidity and mortality in the developed world, estimated to be responsible for hundreds of thousands of deaths annually. Our understanding of the electrophysiological mechanisms of such arrhythmias has grown since they were formally characterized in the late nineteenth century, and this has led to the development of numerous devices and therapies that…
Source: Cardiovascular Drugs and TherapyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Electrical stimulation for low-energy termination of cardiac arrhythmias: a review | #THIPubs @MathewsMakes @MehdiRazavi13 @SpringerCardio #CardiovascDrugsTher https://t.co/yQmt6uyPJi https://t.co/wnC5nhP3Qn
-
-
Mashup Score: 3Electrical Stimulation for Low-Energy Termination of Cardiac Arrhythmias: a Review - Cardiovascular Drugs and Therapy - 3 year(s) ago
Cardiac arrhythmias are a leading cause of morbidity and mortality in the developed world, estimated to be responsible for hundreds of thousands of deaths annually. Our understanding of the electrophysiological mechanisms of such arrhythmias has grown since they were formally characterized in the late nineteenth century, and this has led to the development of numerous devices and therapies that…
Source: Cardiovascular Drugs and TherapyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Dr. Mehdi Razavi and team are exploring the possibility of distributing a pacemaker’s effect across multiple places in the heart using machine learning algorithms. Read more: https://t.co/PrDqmmCQ6i #AI #ArtificialIntelligence @RiceUniversity @MathewsMakes @MehdiRazavi13 https://t.co/iOuNUJa7sZ
-
-
Mashup Score: 0Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance - 3 year(s) ago
Purpose In PARADIGM-HF, sacubitril/valsartan showed a significant reduction in mortality and hospitalization for patients with heart failure with reduced ejection fraction. Despite proven efficacy, sacubitril/valsartan has moderate uptake in clinical practice. This study explores the safety profile of sacubitril/valsartan by comparing adverse events in RCT and real-world use. Methods We studied…
Source: Cardiovascular Drugs and TherapyCategories: Cardiologists, Latest HeadlinesTweet-
Fabulous work by our Internal Medicine residents! Safety analysis of Sacubitril/valsartan using RCTs and RWE. @SarjuGanatraMD @amit5kem Thank you @mvaduganathan ! https://t.co/4rmkHcmN3t
-
-
Mashup Score: 0Role of Bempedoic Acid in Clinical Practice - 3 year(s) ago
Many patients do not achieve optimal low-density lipoprotein cholesterol (LDL-C) levels with statins alone; others are unable to tolerate statin therapy. Additional non-statin treatment options including ezetimibe, proprotein convertase subtilisin/kexin type 9 inhibitors, and bile acid sequestrants are often necessary to further reduce the risk of atherosclerotic cardiovascular disease. This…
Source: Cardiovascular Drugs and TherapyCategories: Cardiologists, Latest HeadlinesTweet-
📁https://t.co/RqoYqXGk7K
-
-
Mashup Score: 0Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment - 3 year(s) ago
Introduction Emerging evidence points to an association between severe clinical presentation of COVID-19 and increased risk of thromboembolism. One-third of patients hospitalized due to severe COVID-19 develops macrovascular thrombotic complications, including venous thromboembolism, myocardial injury/infarction and stroke. Concurrently, the autopsy series indicate multiorgan damage pattern…
Source: Cardiovascular Drugs and TherapyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A review by Gasecka et al #openaccess on Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment https://t.co/kuPl4iGO06 https://t.co/omisvJ5uZQ
-
📁 https://t.co/sAqQnTtUtI